Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

NF-kB p65 antibody (N-Term, NLS Domain)

The Rabbit Polyclonal anti-NF-kB p65 antibody has been validated for WB, IF, EIA and EMSA. It is suitable to detect NF-kB p65 in samples from Human.
Catalog No. ABIN117926

Quick Overview for NF-kB p65 antibody (N-Term, NLS Domain) (ABIN117926)

Target

See all NF-kB p65 (NFkBP65) Antibodies
NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))

Reactivity

  • 481
  • 338
  • 269
  • 40
  • 34
  • 28
  • 23
  • 22
  • 19
  • 14
  • 14
  • 10
  • 5
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 448
  • 44
  • 3
  • 2
  • 1
Rabbit

Clonality

  • 425
  • 73
Polyclonal

Conjugate

  • 274
  • 25
  • 19
  • 13
  • 10
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 5
  • 2
  • 2
This NF-kB p65 antibody is un-conjugated

Application

  • 390
  • 180
  • 145
  • 106
  • 104
  • 91
  • 79
  • 79
  • 78
  • 37
  • 22
  • 10
  • 7
  • 7
  • 7
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA), Electrophoretic Mobility-Shift Assay (EMSA)
  • Binding Specificity

    • 33
    • 31
    • 28
    • 26
    • 23
    • 22
    • 21
    • 20
    • 19
    • 16
    • 15
    • 13
    • 9
    • 9
    • 6
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    N-Term, NLS Domain

    Sequence

    Peptide Sequence: R-I-E-E-K-R-K-R-T-Y-E-T

    Specificity

    This affinity purified antibody is directed against the nuclear localization sequence (NLS) NLS of human p65 and is useful in determining its presence in various assays. The epitope recognized overlaps the NLS of the p65 subunit of the NFκB heterodimer. Therefore, the antibody selectively binds to the activated form of NFκB. Anti-NFκB p65 NLS may react non-specifically with other proteins.

    Purification

    Affinity Purified

    Immunogen

    This antibody was purified from whole rabbit serum prepared by repeated immunizations with the NFkappaB p65 peptide corresponding to the NLS of the human protein conjugated to KLH using maleimide. A residue of cysteine was added to the amino terminal end to facilitate coupling.
  • Application Notes

    Suitable for Immunohistochemistry, Immunoblotting, ELISA and supershift assays. Thisproduct was assayed by Immunoblot and found to be reactive against NFκB p65 NLS at adilution of 1: 2,000 followed by reaction with Peroxidase conjugated Affinity Purified

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL (by UV absorbance at 280 nm)

    Buffer

    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 0.01 % Sodium Azide as preservative.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Dilute only prior to immediate use. Avoid cycles of freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store vial at -20° C or below prior to opening. For extended storage aliquot contents and freeze at -20 °C or below.
  • Target

    NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))

    Alternative Name

    RELA / NF-kB p65

    Background

    NFκB was originally identified as a factor that binds to the immunoglobulin kappa light chain enhancer in B cells. It was subsequently found in non-B cells in an inactive cytoplasmic form consisting of NFκB bound to IκB. NFκB was originally identified as a heterodimeric DNA binding protein complex consisting of p65 (RelA) and p50 (NFKB1) subunits. Other identified subunits include p52 (NFKB2), c-Rel, and RelB. The p65, cRel, and RelB subunits are responsible for transactivation. The p50 and p52 subunits possess DNA binding activity but limited ability to transactivate. p52 has been reported to form transcriptionally active heterodimers with the NFκB subunit p65, similar to p50/p65 heterodimers. Low levels of p52 and p50 homodimers can also exist in cells. The heterodimers of p52/p65 and p50/p65 are regulated by physical inactivation in the cytoplasm by IκB-α. IκB-α binds to the p65 subunit, preventing nuclear localization and DNA binding. IκB- α binding masks the NFκB nuclear localisation signal (NLS). A broad range of external stimuli lead to activation of NFκB and set off signalling cascades that ultimately converge on the IκB kinase (IKK) complex. Activated IKK specifically and directly phosphorylates IκB-α and this phophorylation event targets IκB-α for degradation. As a consequence, NFκB NLS is uncovered and nuclear translocation occurs.Synonyms: NF kappa B p65, NFKB3, NFkB p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, Rel A, Transcription factor p65

    Gene ID

    5970

    NCBI Accession

    NP_001138610

    UniProt

    Q04206

    Pathways

    NF-kappaB Signaling, RTK Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades, S100 Proteins
You are here:
Chat with us!